ProteomicsDB: a multi-omics and multi-organism resource for life science research
暂无分享,去创建一个
Helmut Krcmar | Mathias Wilhelm | Harald Kienegger | Stephan Aiche | Siegfried Gessulat | Maria Reinecke | Hans-Christian Ehrlich | Bernhard Küster | Piero Giansanti | Martin Frejno | Patroklos Samaras | Mathias Wilhelm | H. Krcmar | Siegfried Gessulat | Maria Reinecke | Tobias Schmidt | Hans-Christian Ehrlich | Stephan Aiche | Patroklos Samaras | Harald Kienegger | B. Küster | P. Giansanti | Martin Frejno | J. Mergner | Tobias Schmidt | Anna Jarzab | Jana Zecha | Julia Mergner | Johannes Rank | J. Zecha | A. Jarząb | Johannes Rank
[1] Mathias Wilhelm,et al. A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets , 2015, Molecular & Cellular Proteomics.
[2] The UniProt Consortium,et al. UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..
[3] Chunyu Liu,et al. Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.
[4] F. Arnaud,et al. From core referencing to data re-use: two French national initiatives to reinforce paleodata stewardship (National Cyber Core Repository and LTER France Retro-Observatory) , 2017 .
[5] Antje Chang,et al. The BRENDA Tissue Ontology (BTO): the first all-integrating ontology of all organisms for enzyme sources , 2010, Nucleic Acids Res..
[6] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[7] Mathias Wilhelm,et al. Global proteome analysis of the NCI-60 cell line panel. , 2013, Cell reports.
[8] Joshua A. Bittker,et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action , 2015, Nature chemical biology.
[9] Peer Bork,et al. 20 years of the SMART protein domain annotation resource , 2017, Nucleic Acids Res..
[10] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[11] B. Kuster,et al. Mass-spectrometry-based draft of the human proteome , 2014, Nature.
[12] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[13] Heiner Koch,et al. Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition. , 2015, Journal of proteome research.
[14] B. Kuster,et al. Peptide Level Turnover Measurements Enable the Study of Proteoform Dynamics * , 2018, Molecular & Cellular Proteomics.
[15] Mathias Wilhelm,et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning , 2019, Nature Methods.
[16] Mathias Wilhelm,et al. ProteomeTools: Systematic Characterization of 21 Post-translational Protein Modifications by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Using Synthetic Peptides* , 2018, Molecular & Cellular Proteomics.
[17] Mathias Wilhelm,et al. Building ProteomeTools based on a complete synthetic human proteome , 2017, Nature Methods.
[18] Kaixian Chen,et al. Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation. , 2019, Journal of medicinal chemistry.
[19] Su-In Lee,et al. The proteomic landscape of triple-negative breast cancer. , 2015, Cell reports.
[20] John Crowley,et al. Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat , 2015, BMC Bioinformatics.
[21] B. Kuster,et al. Chemoproteomics‐Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors , 2017, ChemMedChem.
[22] Tsippi Iny Stein,et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.
[23] Marco Beccuti,et al. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets , 2015, Nature Communications.
[24] Heiner Koch,et al. Pharmacoproteomic characterisation of human colon and rectal cancer , 2017, Molecular systems biology.
[25] Mathias Wilhelm,et al. PROCAL: A Set of 40 Peptide Standards for Retention Time Indexing, Column Performance Monitoring, and Collision Energy Calibration , 2017, Proteomics.
[26] M. Monga,et al. Developmental Therapeutics Program at the NCI: molecular target and drug discovery process , 2002, Leukemia.
[27] P. Grandi,et al. Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis , 2018, Cell.
[28] Julio Saez-Rodriguez,et al. OmniPath: guidelines and gateway for literature-curated signaling pathway resources , 2016, Nature Methods.
[29] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[30] Andrea Komljenovic,et al. BgeeDB, an R package for retrieval of curated expression datasets and for gene list expression localization enrichment tests , 2016, F1000Research.
[31] Helmut Krcmar,et al. ProteomicsDB , 2017, Nucleic Acids Res..
[32] B. Kuster,et al. Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs. , 2016, ACS chemical biology.
[33] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[34] Mike Tyers,et al. Gene Information eXtension (GIX): effortless retrieval of gene product information on any website , 2019, Nature Methods.
[35] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[36] G. Drewes,et al. Tracking cancer drugs in living cells by thermal profiling of the proteome , 2014, Science.
[37] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[38] Barry Smith,et al. The Plant Ontology Facilitates Comparisons of Plant Development Stages Across Species , 2019, Front. Plant Sci..
[39] Heiner Koch,et al. The target landscape of clinical kinase drugs , 2017, Science.